•  18
    Shaping Our Selves: On Technology, Flourishing, and a Habit of Thinking by Erik Parens
    Kennedy Institute of Ethics Journal 26 (1): 5-10. 2016.
    In Shaping Our Selves, Erik Parens offers both a personal history of bioethics and a cleverly clarifying lens to train on disputes in bioethics about emerging technologies. The question for readers is whether this lens, as useful as it is, leaves too much outside our field of vision. Parens, born in 1957, comes from the first wave of bioethics scholars—those of us who still mostly happened into bioethics as a field, before it was sufficiently well-established to be identified as a career pathway…Read more
  •  11
    Experimental Treatment Oxymoron or Aspiration?
    Hastings Center Report 25 (4): 6-15. 1995.
  •  46
    Loss of Possession: Concussions, Informed Consent, and Autonomy
    with Richard Robeson
    Journal of Law, Medicine and Ethics 42 (3): 334-343. 2014.
    The principle of informed consent is so firmly established in bioethics and biomedicine that the term was soon bowdlerized in common practice, such that engaging in the informed decision-making process with patients or research subjects is now often called “consenting” them. This evolution, from the original concept to the rather questionable coinage that makes consent a verb, reveals not only a loss of rhetorical precision but also a fundamental shift in the potential meaning, value, and implem…Read more
  •  24
    Conscience, Courage, and “Consent”
    with Mark A. Hall
    Hastings Center Report 46 (2): 30-32. 2016.
    On September 8, 2015, the Department of Health and Human Services issued a Notice of Proposed Rule Making to revise the Federal Policy for the Protection of Human Subjects, widely known as the “Common Rule.” The NPRM proposes several changes to the current system, including a dramatic shift in the approach to secondary research using biospecimens and data. Under the current rules, it is relatively easy to use biospecimens and data for secondary research. This approach systematically facilitates …Read more
  •  14
    Transparency in Neonatal Intensive Care
    Hastings Center Report 22 (3): 18-25. 1992.
  •  5
    Perspective: The Stories We Tell Ourselves
    Hastings Center Report 33 (5). 2003.
  •  20
    Defining and Describing Benefit Appropriately in Clinical Trials
    Journal of Law, Medicine and Ethics 28 (4): 332-343. 2000.
    Institutional review boards and investigators are used to talking about risks of harm. Both low risks of great harm and high risks of small harm must be disclosed to prospective subjects and should be explained and categorized in ways that help potential subjects to understand and weigh them appropriately. Everyone on an IRB has probably spent time at meetings arguing over whether a three-page bulleted list of risk description is helpful or overkill for prospective subjects. Yet only a small fra…Read more
  •  36
    Bad Blood Thirty Years Later: A Q&A with James H. Jones
    with James H. Jones
    Journal of Law, Medicine and Ethics 40 (4): 867-872. 2012.
    Historian James H. Jones published the first edition of Bad Blood, the definitive history of the Tuskegee Syphilis Experiment, in 1981. Its clear-eyed examination of that research and its implications remains a bioethics classic, and the 30-year anniversary of its publication served as the impetus for the reexamination of research ethics that this symposium presents. Recent revelations about the United States Public Health Service study that infected mental patients and prisoners in Guatemala wi…Read more
  •  16
    An open letter to institutional review boards considering northfield laboratories' polyheme® trial
    with Ken Kipnis and Robert M. Nelson
    American Journal of Bioethics 6 (3). 2006.
    At the time of this writing, a widely publicized, waived-consent trial is underway. Sponsored by Northfield Laboratories, Inc. (Evanston, IL) the trial is intended to evaluate the emergency use of PolyHeme®, an oxygen-carrying resuscitative fluid that might prevent deaths from uncontrolled bleeding. The protocol allows patients in hemorrhagic shock to be randomized between PolyHeme® and saline in the field and, still without consent, randomized between PolyHeme® and blood after arrival at an eme…Read more
  •  22
    There's A Lot We Don't Know (and We Ought to Say So)
    American Journal of Bioethics 13 (12): 20-21. 2013.
    No abstract
  •  48
    Athlete or Guinea Pig? Sports and Enhancement Research
    with Richard Robeson
    Studies in Ethics, Law, and Technology 1 (1). 2007.
  •  110
    Studying Benefit in Gene Transfer Research
    with Gail E. Henderson
    IRB: Ethics & Human Research 23 (2): 13. 2001.
  •  13
    The Importance of Amicable and Productive Disagreement
    Journal of Medicine and Philosophy 40 (3): 286-288. 2015.
  •  11
    Reviews in Medical Ethics
    Journal of Law, Medicine and Ethics 37 (1): 147-148. 2009.
  •  59